Eli Lilly and Company: all 2,262 studies
Page 22 of 23. Open to participants first (177), then studies with results posted, then the rest; newest registration first within each.
- A Randomized Study Evaluating the Feasibility and Activity of Three Different Combination With Gemcitabine as First Line Therapy for Non Small Cell Lung CancerCompletedNCT00191490Phase 2
- Long-Term Effects of Insulin Plus Metformin Regimens on the Overall and Postprandial Glycemic Control of Patients With Type 2 DiabetesCompletedNCT00191464Phase 4
- Phase III Study of Gemcitabine Plus a Cytotoxic Agent Versus Two Cytotoxic AgentsCompletedNCT00191438Phase 3
- 2-Year Therapy With Teriparatide vs 1-yr Therapy Followed by 1-Year of Raloxifene or Calcium/Vit D in Severe Postmenopausal OsteoporosisCompletedNCT00191425Phase 4
- A Study of Pemetrexed in the Treatment of Patients With Advanced Metastatic Cancer of the LiverCompletedNCT00191412Phase 2
- Bipolar Depression Study: Bipolar Depression Assessment Study on Treatment ResponseCompletedNCT00191399Phase 4
- A Trial for HER2 Positive Breast Cancer Patients With Metastatic DiseaseCompletedNCT00191373Phase 2
- Extension Study on Safety of Long-Term Growth Hormone Replacement in Adult Patients With Growth Hormone DeficiencyCompletedNCT00191360Phase 3
- A Study of Biweekly Pemetrexed and Gemcitabine in Patients With Metastatic Breast CancerCompletedNCT00191347Phase 2
- Teriparatide Use in Hip Replaced SubjectsCompletedNCT00191321Phase 3
- Atomoxetine Versus Placebo in Children With Attention Deficit/Hyperactivity Disorder (ADHD)CompletedNCT00191295Phase 2/3
- Efficacy Trial of Gemcitabine Containing Regimens As Preoperative Chemotherapy in Non Small Cell Lung CancerCompletedNCT00191256Phase 2
- Docetaxel vs. Docetaxel-Gemcitabine in Breast CancerCompletedNCT00191243Phase 2
- Gemcitabine/Platinum Containing Regimens as Preoperative Chemotherapy for Patients With Non Small Cell Lung CancerCompletedNCT00191230Phase 2
- Open Label Phase III Duloxetine Study for Stress Urinary IncontinenceCompletedNCT00191204Phase 3
- Effects of Insulin in Perceived Mood Symptoms in Patients With Type 2 DiabetesCompletedNCT00191178Phase 4
- Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcitabine-Cisplatin in Early Stages NSCLCCompletedNCT00191126Phase 3
- Duloxetine in the Treatment of Stress Urinary Incontinence.CompletedNCT00191087Phase 3
- Amendment (g) Unblinded Extension Phase of Somatropin in Patients With Idiopathic Short StatureCompletedNCT00191074Phase 3
- A Comparison of Tolerability and Efficacy of Different Doses of Duloxetine for the Treatment of Major Depressive DisorderCompletedNCT00191061Phase 4
- Treatment With Atomoxetine Hydrochloride in Children and Adolescents With ADHDCompletedNCT00191048Phase 4
- Maintenance of Benefit With Atomoxetine Hydrochloride in Adolescents With ADHDCompletedNCT00191035Phase 4
- Comparison of LY686017 With a Marketed Drug in the Treatment of Social Anxiety DisorderCompletedNCT00191022Phase 2
- Adding Atomoxetine To Standard Medication Treatment In Patients With Alzheimer's DiseaseCompletedNCT00191009Phase 2/3
- Evaluate Safety and Efficacy of Duloxetine in Predominant Stress Urinary IncontinenceCompletedNCT00190996Phase 3
- Atomoxetine Treatment of Adults With ADHD and Comorbid Alcohol AbuseCompletedNCT00190957Phase 4
- Effects of Teriparatide on Distal Radius Fracture HealingCompletedNCT00190944Phase 2
- A Functional Outcomes Study With Atomoxetine-Hydrochloride and Placebo in Adults With Attention-Deficit/Hyperactivity DisorderCompletedNCT00190931Phase 4
- A Trial for Patients With Gestational Trophoblastic DiseaseCompletedNCT00190918Phase 2
- Safety and Effectiveness Study of Duloxetine HCl in Women of Different Backgrounds With Stress Urinary Incontinence Who May Also Have Other Various Medical Conditions.CompletedNCT00190905Phase 4
- Olanzapine Plus Carbamazepine in the Treatment of Bipolar I ManiaCompletedNCT00190892Phase 4
- Placebo-Controlled Study of Atomoxetine Hydrochloride in the Treatment of Adults With ADHD and Comorbid Social Anxiety DisorderCompletedNCT00190879Phase 4
- Study of Duloxetine Versus Placebo in the Treatment of Fibromyalgia SyndromeCompletedNCT00190866Phase 3
- Biomechanical and Electrophysiological Effects of Duloxetine in the Treatment of Women With Urinary Stress IncontinenceCompletedNCT00190853Phase 3
- A Single Arm Phase 2 Study of Pemetrexed as 2nd-Line Treatment of Advanced Non-Small Cell Lung CancerCompletedNCT00190840Phase 2
- Effectiveness of Duloxetine in the Treatment of Stress Urinary Incontinence(Uncontrolled Leakage of Urine)CompletedNCT00190827Phase 3
- Effectiveness and Safety of Duloxetine in Women Experiencing Urinary Leakage Due to Physical Stress and Urge.CompletedNCT00190814Phase 3
- Phase 2 Study on Use of a Combination of Pemetrexed in Patients With Advanced Gastric CarcinomaCompletedNCT00190801Phase 2
- Extended Therapy of Drotrecogin Alfa (Activated) 4 vs 7 Days InfusionCompletedNCT00190788Phase 3
- A Study Comparing Pemetrexed Plus Best Supportive Care Versus Best Supportive Care Alone in the Treatment of MesotheliomaCompletedNCT00190762Phase 3
- Efficacy and Safety of Once-Daily Atomoxetine Hydrochloride in Adults With ADHD Over an Extended Period of Time (6 Months)CompletedNCT00190736Phase 4
- A Study of LY317615 in Patients With Brain TumorsCompletedNCT00190723Phase 2
- A Trial of Carboplatin and Gemcitabine Versus Gemcitabine Alone in Patients With Non-Small-Cell Lung CancerCompletedNCT00190710Phase 3
- A Study of LY353381 (Arzoxifene) for Patients Who Benefitted From This Drug in Other Oncology Trials and Wished to Continue TreatmentCompletedNCT00190697Phase 4
- Somatropin Treatment in Patients With SHOX Deficiency and Turner SyndromeCompletedNCT00190658Phase 3
- To Evaluate the Safety of Duloxetine in Patients With Stress Urinary IncontinenceCompletedNCT00190645Phase 3
- To Evaluate the Safety in Patients Taking Duloxetine for Stress Urinary IncontinenceCompletedNCT00190632Phase 3
- Efficacy and Safety of DuloxetineCompletedNCT00190619Phase 3
- Efficacy and Safety of Duloxetine, Placebo and Pelvic Floor Muscle Training in Subjects With Stress Urinary IncontinenceCompletedNCT00190606Phase 2
- Raloxifene Use for The HeartCompletedNCT00190593Phase 3
- Biomechanical Effects of Duloxetine on Bladder and Sphincter Muscle Function in Women in Pure Genuine Stress IncontinenceCompletedNCT00190567Phase 2
- A Phase I Study of Cetuximab in Combination With Gefitinib in Patients With Advanced/Metastatic Non-Small Cell Lung CancerCompletedNCT00162318Phase 1
- A Trial of Erbitux for Recurrent and Metastatic Mucinous Gastrointestinal Adenocarcinoma Involving the Peritoneal SurfacesCompletedNCT00162110Phase 2
- Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPDCompletedNCT00157339Phase 3
- Tadalafil in Subjects With Mild to Moderate HypertensionCompletedNCT00157326Phase 2
- A Study in People With High CholesterolCompletedNCT00133380Phase 2
- Study of Human Insulin Inhalation Powder in Patients With Type 1 DiabetesCompletedNCT00127634Phase 3
- PHIRST-1: Tadalafil in the Treatment of Pulmonary Arterial HypertensionCompletedNCT00125918Phase 3
- A Study of Duloxetine in the Treatment of FibromyalgiaCompletedNCT00125892Phase 3
- Duloxetine Compared With Placebo in the Prevention of Relapse in Generalized Anxiety DisorderCompletedNCT00122863Phase 3
- A Comparison of Duloxetine Hydrochloride, Marketed Comparator, and Placebo in the Treatment of Generalized Anxiety DisorderCompletedNCT00122850Phase 3
- A Comparison of Duloxetine Hydrochloride, Marketed Comparator, and Placebo in the Treatment of Generalized Anxiety DisorderCompletedNCT00122837Phase 3
- Duloxetine Compared With Placebo in Patients With Generalized Anxiety DisorderCompletedNCT00122824Phase 3
- A Study in People With Abnormal Fat Levels in the BloodCompletedNCT00116519Phase 2
- Olanzapine Treated Adolescents With Schizophrenia or Bipolar I DisorderCompletedNCT00113594Phase 3
- Study of Gemcitabine/Platinum +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung CancerCompletedNCT00112346Phase 2
- Comparing Pre-Mixed Insulin With Insulin Glargine Combined With Rapid-Acting Insulin in Patients With Type 2 DiabetesCompletedNCT00110370Phase 4
- Study of Pemetrexed in the Treatment of Patients With Ovarian Cancer Who Have Failed Prior Platinum-Based ChemotherapyCompletedNCT00109096Phase 2
- Enzastaurin as Second and Third-Line Treatment for Non-Small Cell Lung Cancer.CompletedNCT00105092Phase 2
- Olanzapine Versus Aripiprazole in the Treatment of Acutely Ill Patients With SchizophreniaCompletedNCT00103571Phase 4
- A Study of Pemetrexed Plus Doxorubicin Given to Patients With Advanced Breast CancerCompletedNCT00102219Phase 2
- Gemcitabine and Platinol Followed by Pemetrexed and Gemcitabine in Patients With Advanced or Metastatic Bladder CancerCompletedNCT00101842Phase 1/2
- Efficacy of High Dose Olanzapine for the Treatment of Schizophrenia and Schizoaffective DisorderCompletedNCT00100776Phase 4
- Comparing Intensive and Standard Training for Human Insulin Inhalation Powder (HIIP)CompletedNCT00099515Phase 2
- Study of Alimta and Epirubicin Administered in Patients With Locally Advanced or Metastatic Breast CancerCompletedNCT00097383Phase 1/2
- Trial of Carboplatin/Paclitaxel/Cetuximab in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00097227Phase 2
- Carboplatin Plus Cetuximab for Treatment of Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00097214Phase 2
- Pharmacokinetic Characterization of Intramuscular Olanzapine DepotCompletedNCT00094640Phase 1
- Olanzapine vs. Comparator and Placebo in the Treatment of Patients With Bipolar I DisorderCompletedNCT00094549Phase 4
- Olanzapine in Patients With Borderline Personality DisorderCompletedNCT00091650Phase 3
- Comparison of Continuing Olanzapine to Switching to Quetiapine in Overweight or Obese Patients With Schizophrenia and Schizoaffective DisorderCompletedNCT00090012Phase 4
- A Combination of Two Currently Approved Drugs to Enhance the Treatment of SchizophreniaCompletedNCT00089869Phase 1/2
- Comparison of Intramuscular Olanzapine Depot to Oral Olanzapine and Low-Dose Depot in Patients With SchizophreniaCompletedNCT00088491Phase 3
- Comparison of Intramuscular Olanzapine Depot With Placebo in the Treatment of Patients With SchizophreniaCompletedNCT00088478Phase 3
- Study of Olanzapine vs. Aripiprazole in the Treatment of SchizophreniaCompletedNCT00088049Phase 4
- Efficacy and Safety of Olanzapine in Patients With Borderline Personality DisorderCompletedNCT00088036Phase 3
- Effects of Arzoxifene on Bone Fractures and Incidence of Breast CancerCompletedNCT00088010Phase 3
- A Randomized Phase 3 Trial of Pemetrexed and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Locally Advanced or Metastatic Non Small Cell Lung CancerCompletedNCT00087711Phase 3
- Effects of Arzoxifene on Bone Mass and the UterusCompletedNCT00085956Phase 3
- A Study in Patients With Persistent or Recurrent Epithelial Ovarian or Primary Peritoneal CarcinomaTerminatedNCT00082212Phase 2
- Effects of Teriparatide in Postmenopausal Women With OsteoporosisCompletedNCT00079924Phase 4
- Pemetrexed Plus a Comparator Versus a Combination of 2 Comparators in First-Line Treatment of Colorectal CancerCompletedNCT00079872Phase 2
- A Comparison of Two Doses of Pemetrexed in Patients Who Have Lung CancerCompletedNCT00078260Phase 3
- New Oral Anticoagulant Therapy for the Prevention of Blood Clots Following Hip or Knee Replacement SurgeryCompletedNCT00074828Phase 2
- Duloxetine Compared to Escitalopram and Placebo in the Treatment of Patients With DepressionCompletedNCT00073411Phase 3
- Pemetrexed and Carboplatin in Locally Advanced or Metastatic Breast CancerCompletedNCT00072865Phase 2
- Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neuroscience Duloxetine Clinical TrialApproved for marketingNCT00071708
- Duloxetine vs. Active Comparator in the Treatment of Patients With DepressionCompletedNCT00071695Phase 4
- Pemetrexed and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00071136Phase 1/2
- A Study With Gemcitabine, Cisplatin, and LY293111 in Non-Small Cell Lung CancerCompletedNCT00069875Phase 2